Home Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
Article Open Access

Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia

  • Fang Wang , Lili Xu , Mingming Qi , Huimin Lai , Fanhua Zeng , Furong Liang , Qing Wen , Xihua Ma , Chan Zhang and Kaili Xie EMAIL logo
Published/Copyright: February 28, 2023

Abstract

This study set out to determine the key metabolite changes underlying the pathophysiology of severe preeclampsia (PE) using metabolic analysis. We collected sera from 10 patients with severe PE and from 10 healthy pregnant women of the same trimester and analyzed them using liquid chromatography mass spectrometry. A total of 3,138 differential metabolites were screened, resulting in the identification of 124 differential metabolites. Kyoto encyclopedia of genes and genomes pathway analysis revealed that they were mainly enriched in the following metabolic pathways: central carbon metabolism in cancer; protein digestion and absorption; aminoacyl-transfer RNA biosynthesis; mineral absorption; alanine, aspartate, and glutamate metabolism; and prostate cancer. After analysis of 124 differential metabolites, 2-hydroxybutyric acid was found to be the most critical differential metabolite, and its use allowed the differentiation of women with severe PE from healthy pregnant women. In summary, our analysis revealed that 2-hydroxybutyric acid is a potential key metabolite for distinguishing severe PE from healthy controls and is also a marker for the early diagnosis of severe PE, thus allowing early intervention.

1 Introduction

Preeclampsia (PE) is defined as a new onset of hypertension during pregnancy after the 20th week [1], and its global prevalence is 8% [2]. Worldwide, PE and eclampsia are major causes of maternal and infant mortality [3]. In developing countries, it occurs at a rate of 1.8–16.7% [4] and causes 40–60% of maternal deaths [4]. Its rates have remained unchanged for decades, but the rates of severe PE have increased over recent decades [5]. Eclampsia can occur in patients with severe PE leading to symptoms of the nervous system [6] or hemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome [7]. Depending on the clinical characteristics of a patient, PE can be classified as mild or severe [8]. Furthermore, it can be classified according to its time of clinical manifestation as “early-onset PE” (EOPE) in cases occurring before 34 weeks of pregnancy, or as “late-onset PE” (LOPE) in cases occurring after 34 weeks of pregnancy [9]. EOPE and LOPE might be more useful subclassifications [10]. The majority of the affected women suffers from PE at the late preterm or term stage, but about 12% suffers from PE that begins early (before 34 weeks of pregnancy) [11]. EOPE is the result of placental defects and deficiency of trophoblast invasion and normal spiral artery remodeling; LOPE, however, may result from interactions between the normal senescence of the placenta and a maternal genetic history of cardiovascular disease [12,13]. Blood pressure (BP) control is crucial during PE to prevent systemic complications [14]. Therefore, early diagnosis and early intervention in PE are particularly important.

There are many established risk factors for PE, such as nulliparity, advanced maternal age, overweight or obesity, chronic hypertension, diabetes, previous PE, family history of PE, and multiple pregnancy [15]; however, the exact causes of PE/eclampsia remain unclear [16]. Further research is needed concerning the cellular and molecular mechanisms of PE to improve the treatment of PE patients [17].

The study of metabonomics and metabolomics involves the use of accurate metabonomic (and/or metabolomic) analyses of metabolic changes occurring in cells, tissues, and whole organisms [18]. It is part of the “omics cascade” together with genomics, transcriptomics, and proteomics [19] and one of the many “-omics” technologies that are currently being developed [20]. Metabolomics, or metabonomics, primarily involves the elucidation of the end products in a specific organism or a cell [21], and it is the “ultimate” tool in the “omics chain,” as it is the closest to the phenotype [22]. It can be divided into two categories: untargeted and targeted [23]. While the former also known as discovery metabolomics, which is a global analysis of different metabolomics between control and experimental groups, the latter focuses on the analysis of specific metabolic clusters associated with certain metabolic pathways [20].

2-Hydroxybutyric acid is elevated in many diseases and has some diagnostic values. In cancer, its levels have been elevated in a mouse model of colon carcinogenesis induced by azoxymethane/dextran sodium sulfate [24]; furthermore, nuclear lactate dehydrogenase A induces its production from reactive oxygen species and promotes human papilloma virus-induced cervical tumor growth [25]; moreover, patients in the initial diagnostic stage of acute myeloid leukemia can be identified by 2-hydroxybutyric acid [26]. In pneumonia diseases, compared to healthy controls, 2-hydroxybutyric acid was found to be enriched in COVID-19 patients and COVID-like patients and remained at higher levels after discharge [27]; meanwhile, elevated dehydrogenase can be an independent prognostic factor for death in hospitalized COVID-19 patients [28]; it also has a diagnostic value in community-acquired pneumonia [29]. 2-Hydroxybutyric acid has been more deeply studied in diabetes than in any other disease, and high levels of plasma are a good predictor of type 2 diabetes [30]. Furthermore, it can be used in the following circumstances: as a biomarker of insulin resistance; for disease tracking throughout the treatment of insulin resistance [31]; as a predictive marker for impaired glucose tolerance without the need for a glucose tolerance test [32]; along with branched-chain amino acids, it can predict worsening glycemic control in adolescents [33]; it has high values in the sera of patients with isolated postchallenge diabetes compared to normal subjects [34]; and its levels decrease significantly after laparoscopic sleeve gastrectomy in morbidly obese patients [35]. It also have some diagnostic values in other diseases: it is significantly higher in the blood of pregnant women carrying trisomy 21 fetuses than in healthy pregnant women [36]; urinary 2-hydroxybutyric acid predicts the development of acute kidney injury in presurgical samples [37]; and its levels are elevated in patients with a major depressive disorder [38].

In this study, we collected sera from 10 patients with severe PE and 10 healthy pregnant women of the same trimester and analyzed them using liquid chromatograph mass spectrometry (LC-MS), with a view to identifying the key metabolites of the former pathogenesis and providing new indicators for early diagnosis.

2 Materials and methods

2.1 Study population

All samples were obtained from the Obstetrics Department of Zhuzhou Central Hospital and were divided into a normal control group (10 normotensive pregnant women) and a severe PE group (n = 10). The basic diagnostic criteria for PE are as follows: BP ≥140/90 mmHg, and urine protein ≥0.3 mg/24 h. Severe PE is diagnosed on the basis of the diagnostic criteria for PE with any of the following conditions present: systolic BP ≥160 mmHg, or diastolic BP ≥110 mmHg, or other manifestations of a multisystem disorder (e.g., severe proteinuria, thrombocytopenia, impaired liver function, severe persistent right upper quadrant or epigastric pain, renal insufficiency, pulmonary edema, or new-onset headache).

  1. Informed consent: Informed consent has been obtained from all individuals included in this study.

  2. Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance with the tenets of the Helsinki Declaration, and has been approved by the Institutional Research Ethics Board of Zhuzhou Central Hospital (reference number 20180334).

2.2 Sample processing

A peripheral blood sample (10 mL) was taken from each participant. All samples were centrifuged at 2,000 rpm for 10 min at room temperature using a centrifuge. Afterward, the supernatant was stored in a refrigerator at −80°C.

2.3 Spectroscopy

All samples were thawed at 4°C (insufficient samples were reduced to an equal scale); 100 µL of each sample was transferred into 2 mL centrifuge tubes (samples with a sample size of <50 µL were extracted by half of the experimental system, but the resolution system remained unchanged); 400 µL of methanol (−20°C) was added to each tube and vortexed for 60 s; the mixture was centrifuged at 4°C for 10 min at 12,000 rpm, and then the supernatant was transferred from each sample into another 2 mL centrifuge tube. Samples were concentrated to dry in a vacuum and subsequently dissolved with 150 µL 2-chlorobenzalanine (4 ppm) 80% methanol solution, and the supernatant was filtered through a 0.22 µm membrane to obtain the prepared samples for gas chromatography mass spectrometry (GC-MS). For quality control (QC), 20 µL subsamples were taken (QC samples were used to monitor deviations of the analytical results from these pool mixtures and compare them to the errors caused by the analytical instrument itself). The remainder of the samples were used for LC-MS detection

2.4 Chromatography and mass spectrometry conditions

Chromatographic separation was performed with an ACQUITY UPLC® HSS T3 (150 mm × 2.1 mm, 1.8 µm, Waters) column maintained at 40°C. The temperature of the autosampler was 8°C. Gradient elution of analytes was carried out with 0.1% formic acid in water and 0.1% formic acid in acetonitrile or 5 mM ammonium formate in water and acetonitrile at a flow rate of 0.25 mL/min. Injection of 2 μL of each sample was performed after equilibration. An increasing linear gradient of solvent B (v/v) was used as follows: 0–1 min, 2% B/D; 1–9 min, 2–50% B/D; 9–12 min, 50–98% B/D; 12–13.5 min, 98% B/D; 13.5–14 min, 98–2% B/D; 14–20 min, 2% D-positive model (14–17 min, 2% B-negative model).

The electrospray ionization multistage mass spectrometry experiments were used with a spray voltage of 3.5 and −2.5 kV in positive and negative modes, respectively. Sheath gas and auxiliary gas were set at 30 and 10 arbitrary units, respectively, while the capillary temperature was 325°C. The Orbitrap analyzer scanned over a mass range of m/z 81–1,000 for a full scan at a mass resolution of 70,000. Data-dependent acquisition MS/MS experiments were performed with a higher energy collisional dissociation scan. The normalized collision energy was 30 eV. Dynamic exclusion was implemented to remove some unnecessary information in MS/MS spectra.

2.5 Multivariate statistical analysis

The data were analyzed using SIMCA-P (v13.0) [35] software and the R language ropls [39] package. The main methods of analysis included principal component analysis (PCA), partial least squares-discriminant analysis (PLS-DA), and orthogonal partial least squares discriminant analysis (OPLS-DA) [40].

Unsupervised analysis (e.g., PCA) does not ignore within-group errors, eliminates random errors that are not relevant to the purpose of the study, focuses too much on details, and neglects the overall picture and patterns, and is ultimately detrimental to the detection of between-group differences and differential compounds. In such cases, it is necessary to use prior knowledge of the sample to further focus the data analysis on the aspect being studied, using a supervised analysis such as PLS-DA. OPLS-DA, another commonly used method in metabolomics data analysis, is an extension of PLS-DA. Compared to the PLS-DA, this method can effectively reduce the complexity of the model and enhance the explanatory power of the model without reducing the predictive power, thus maximizing the differences between groups.

3 Analysis and identification of metabolites

3.1 Differential metabolite screening

Metabolites are screened to identify differential metabolites (biomarkers); the relevant conditions are as follows: p-value ≤0.05 + VIP (variable importance for the projection) ≥1.

3.2 Identification of metabolites

Metabolite identification was first confirmed on the basis of precise molecular weights (molecular weight error <30 ppm), followed by confirmation of annotation against the Metlin (http://metlin.scripps.edu) and MoNA (https://mona.fiehnlab.ucdavis.edu//) databases based on MS/MS fragmentation patterns to identify the final metabolites.

3.3 Network analysis

Metscape [41], a Cytoscape plug-in (v.3.9.0) [42], was used for the metabolic network analysis and data visualization.

3.4 Kyoto encyclopedia of genes and genomes (KEGG) analysis

MetPA is part of metaboanalyst (www.metaboanalyst.ca) and is based on the KEGG metabolic pathway. The MetPA database identifies possible bioturbated metabolic pathways through metabolic pathway enrichment and topology analysis, and thus analyzes the metabolic pathways of metabolites. The MetPA database allows the analysis of metabolic pathways associated with two sets of differential metabolites, using a hypergeometric test as the data analysis algorithm, and relative-betweeness centrality for pathway topology.

4 Results

4.1 Subject characteristics

Ten healthy pregnant women of the same trimester and 10 pregnant women with severe PE were included in this study. There were no significant differences between the two groups when subject characteristics such as age (31.6 ± 5.77) or week of gestation (32.1 ± 1.72 W) were taken into account. However, there were significant differences in BP, gestational week at termination, neonatal Apgar score, and neonatal weight. Table 1 shows the clinical features of the 10 severe PE cases.

Table 1

Severe PE clinical features

NO Age (years) Gestational weeks Systolic pressure (mmHg) Edema 24 h urine protein (g/L) Albumin Ultrasound of pleural and peritoneal effusion Time to terminate pregnancy Neonatal Apgar Scores Neonatal weight (g) Echocard-iography
1 25 33 + 3 116–151 Normal 11.120 22.6 g/L Normal 34 weeks 8–10 1,600 Normal
2 32 29 + 5 109–161 (+) 0.603 Normal Normal 30 + 6 9–10 1,270 Normal
3* 31 31 + 5 100–139 (+) 0.378 25.2 g/L Normal 35 + 1 9–10 2,160 and 2,420 (twins) Normal
4 29 32 + 3 120–160 Normal 1.229 Normal Normal Leave hospital Leave hospital Leave hospital Normal
5 33 31 + 2 150–175 Normal Leave hospital Leave hospital Normal Leave hospital Leave hospital Leave hospital Normal
6 45 32 + 6 107–166 Normal 5.292 24 g/L Normal 32 + 6 7–10 1,250 Normal
7 31 29 130–170 Normal 6.134 Normal Normal 29 + 2 0 1,050 <5 mL
8 24 32 + 6 122–161 (++++) 4.772 27.2 g/L Pleural effusion 33 + 2 9–10 1,640 Normal
9 34 33 + 3 110–147 (++) 0.454 25.1 g/L Pleural effusion 33 + 3 8–10 1,720 and 1,790 (twins) Normal
10 34 34 + 3 118–175 (+++) 1.742 26.5 g/L Pleural effusion 34 + 6 8–10 1,920 and 1,890 (twins) Normal

Note: NO 7, The patient requested induction of labor, rivanol amniotic injection at 29 + 2 weeks, neonatal death. No 3 had a diastolic BP of 110 mmHg. *Had a diastolic BP of 110 mmHg.

4.2 Multivariate analysis

In this study, serum samples from the 10 healthy pregnant women and 10 severe PE patients were analyzed with a metabolomics approach, using GC-MS followed by the multivariate data analysis by PCA, PLS-DA, and OPLS-DA (Table 2). Initial unsupervised PCA (Figure 1a) and supervised PCA (Figure 1b and c) showed a clear separation of metabolites between the normal and severe EOPE groups.

Table 2

Multivariate data analysis result

PE vs Normal Pre R2X (cum) R2Y (cum) Q2 (cum)
PCA 4 0.511
PLS-DA 3 0.432 0.998 0.962
OPLS-DA 1 + 1 + 0 0.356 0.973 0.895
Figure 1 
                  (a) PCA, (b) PLS-DA, and (c) OPLS-DA of the severe EOPE and normal groups.
Figure 1

(a) PCA, (b) PLS-DA, and (c) OPLS-DA of the severe EOPE and normal groups.

4.3 Identified metabolites

In the GC-MS analysis, 3138 differential metabolites were screened and 124 metabolites (Figure 2) were eventually identified. Of the 124 identified differential metabolites, 45 downregulated products and 79 upregulated products were included. The classification of the identified differential metabolites are summarized in Figure 3; these were mainly located on metabolism of amino acids, carbohydrates, cofactors and vitamins, lipids, nucleotides, and peptides.

Figure 2 
                  Heatmap with all the significant metabolites.
Figure 2

Heatmap with all the significant metabolites.

Figure 3 
                  Classification of identified differential metabolites. The differential metabolites located on metabolism of amino acids, carbohydrates, cofactors and vitamins, lipids, nucleotides, and peptides.
Figure 3

Classification of identified differential metabolites. The differential metabolites located on metabolism of amino acids, carbohydrates, cofactors and vitamins, lipids, nucleotides, and peptides.

4.4 Network analysis

By building an association-based network, we found that 2-hydroxybutyric acid was important within this metabolic network (Figure 4). Furthermore, the results of the differential metabolite analysis showed that 2-hydroxybutyric acid differed significantly between preeclamptic and normal pregnant women (VIP = 1.670, p-value <0.05, false discovery rate (FDR) = 0.006, log FC = 1.016). Meanwhile, the results of analysis of variance for l-threonine and 5,6-dihydro-5-fluorouracil were VIP = 1.695, p-value <0.05, FDR = 0.022, log FC = 1.036; and VIP = 1.654, p-value <0.05, FDR = 0.006, log FC = 1.020, respectively. In the ROC plot (Figure 5), there was an area under the curve (AUC) of 0.99, indicating a high level of accuracy (high accuracy = AUC >0.9).

Figure 4 
                  Network analysis of identified differential metabolites. 2-Hydroxybutyric acid was identified as the key metabolite in a network analysis based on VIP and FDR values.
Figure 4

Network analysis of identified differential metabolites. 2-Hydroxybutyric acid was identified as the key metabolite in a network analysis based on VIP and FDR values.

Figure 5 
                  ROC plot of 2-hydroxybutyric acid and the concentrations of 2-hydroxybutyric acid in PE group and normal group. (a) There was an AUC of 0.99. (b) The concentrations of 2-hydroxybutyric acid is 47559849.097 ± 14839964.376 in the PE group and 23509331.240 ± 4802006.390 in the normal group.
Figure 5

ROC plot of 2-hydroxybutyric acid and the concentrations of 2-hydroxybutyric acid in PE group and normal group. (a) There was an AUC of 0.99. (b) The concentrations of 2-hydroxybutyric acid is 47559849.097 ± 14839964.376 in the PE group and 23509331.240 ± 4802006.390 in the normal group.

4.5 KEGG analysis

The final results of the differential metabolite KEGG pathway enrichment analysis are shown in Figure 6. Significantly enriched pathways included central carbon metabolism in cancer, protein digestion and absorption, aminoacyl-transfer RNA (tRNA) biosynthesis, mineral absorption, alanine, aspartate and glutamate metabolism, and prostate cancer (FDR <0.05).

Figure 6 
                  KEGG pathway analysis of identified differential metabolites. Significantly enriched pathways include central carbon metabolism in cancer (37 differential metabolites); protein digestion and absorption (47 differential metabolites); aminoacyl-tRNA biosynthesis (52 differential metabolites); mineral absorption (29 differential metabolites); alanine, aspartate, and glutamate metabolism (28 differential metabolites); prostate cancer (11 differential metabolites) (FDR <0.05). The size of the circle represents the number of differential metabolites that are enriched in this pathway. −log(p): Negative values for the natural logarithm of the p-value. Impact: Metabolic pathway impact values.
Figure 6

KEGG pathway analysis of identified differential metabolites. Significantly enriched pathways include central carbon metabolism in cancer (37 differential metabolites); protein digestion and absorption (47 differential metabolites); aminoacyl-tRNA biosynthesis (52 differential metabolites); mineral absorption (29 differential metabolites); alanine, aspartate, and glutamate metabolism (28 differential metabolites); prostate cancer (11 differential metabolites) (FDR <0.05). The size of the circle represents the number of differential metabolites that are enriched in this pathway. −log(p): Negative values for the natural logarithm of the p-value. Impact: Metabolic pathway impact values.

5 Discussion

In this study, we analyzed the metabolites in the sera of 10 severe PE cases and 10 healthy pregnant women. A total of 3,138 differential metabolites were screened, resulting in the identification of 124 differential metabolites. After analysis of 124 differential metabolites, 2-hydroxybutyric acid was found to be the more critical differential metabolite; its presence clearly distinguished between severe PE and healthy pregnant women. The analysis of the KEGG pathway revealed that the metabolites were mainly enriched in the following metabolic pathways: central carbon metabolism in cancer; protein digestion and absorption; aminoacyl-tRNA biosynthesis; mineral absorption; alanine, aspartate, and glutamate metabolism; prostate cancer.

2-Hydroxybutyric acid is predominantly produced during the metabolism of l-threonine or the synthesis of glutathione and may be elevated by oxidative stress or the detoxification of exogenous substances in the liver [43]. It has been previously demonstrated that 2-hydroxybutyric acid, as a component of a metabolite-only model, can predict the EOPE [44]. Our study also found that this metabolite played an important role in severe PE; however, we used a different approach.

Two of the KEGG enrichment analyses differential metabolites that we studied were associated with cancer. The other four KEGG pathways were all found to be associated with severe PE. The differential mRNAs between the preeclamptic and normal groups were also found to be enriched in the protein digestion and absorption pathways [45]. Thus, previous studies have found that l-arginine supplementation can be used to treat individuals with PE [46]. Harville et al. demonstrated that aminoacyl-tRNA biosynthesis is associated with hypertensive disorders of pregnancy [47]. Furthermore, the relationship between minerals and PE has been relatively well studied. Serum selenium levels have been shown to be associated with PE in several studies [4851]; however, amniotic fluid selenium status has been shown to be uncorrelated with PE or preterm delivery [52,53]. On the other hand, Enebe et al. found that low levels of antioxidant trace elements, for example, selenium, copper, and magnesium, can promote the incidence of PE [54], and other studies have found that mineral and vitamin supplementation can reduce the incidence [55,56]. These findings illustrate the impact of mineral absorption pathways on PE. To our knowledge, there is no literature addressing the relationship between the alanine, aspartate, and glutamate metabolism pathway and PE. However, a proportion of patients with PE do have abnormal liver function.

In summary, our analysis revealed that 2-hydroxybutyric acid might be a key metabolite for distinguishing severe PE from normal controls and is potentially a marker for the early diagnosis of severe PE, thus providing a basis for early detection and intervention.

Acknowledgments

We thank Dr Huan Chen for his guidance in writing the manuscript.

  1. Funding information: This manuscript was supported by the Hunan Provincial Natural Science Foundation (Grant No. 2019JJ60089).

  2. Author contributions: Fang Wang and Kaili Xie contributed to the conception of the study; Mingming Qi and Xihua Ma performed the experiment; Lili Xu and Furong Liang contributed significantly to analysis and manuscript preparation; Huimin Lai and Chan Zhang performed the data analyses and wrote the manuscript; Fanhua Zeng and Qing Wen helped perform the analyses and contributed to constructive discussions.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Deer E, Jones J, Cornelius DC, Comley K, Herrock O, Campbell N, et al. Progesterone induced blocking factor reduces hypertension and placental mitochondrial dysfunction in response to sFlt-1 during pregnancy. Cells. 2021 Oct 20;10(11):2817. 10.3390/cells10112817. PMID: 34831040. PMCID: PMC8616090.Search in Google Scholar PubMed PubMed Central

[2] Tianthong W, Phupong V. Serum hypoxia-inducible factor-1α and uterine artery Doppler ultrasound during the first trimester for prediction of preeclampsia. Sci Rep. 2021 Mar 23;11(1):6674. 10.1038/s41598-021-86073-w. PMID: 33758274. PMCID: PMC7988168.Search in Google Scholar PubMed PubMed Central

[3] Daniels K, Lewin S, Practice Policy Group. Translating research into maternal health care policy: a qualitative case study of the use of evidence in policies for the treatment of eclampsia and pre-eclampsia in South Africa. Health Res Policy Syst. 2008 Dec 17;6:12. 10.1186/1478-4505-6-12. PMID: 19091083. PMCID: PMC2645395.Search in Google Scholar PubMed PubMed Central

[4] Birhanu MY, Temesgen H, Demeke G, Assemie MA, Alamneh AA, Desta M, et al. Incidence and predictors of pre-eclampsia among pregnant women attending antenatal care at debre markos referral hospital, North West Ethiopia: Prospective cohort study. Int J Womens Health. 2020 Nov 10;12:1013–21. 10.2147/IJWH.S265643. PMID: 33204174. PMCID: PMC7667502.Search in Google Scholar PubMed PubMed Central

[5] Eddy AC, Bidwell GL 3rd, George EM. Pro-angiogenic therapeutics for preeclampsia. Biol Sex Differ. 2018 Aug 25;9(1):36. 10.1186/s13293-018-0195-5. PMID: 30144822. PMCID: PMC6109337.Search in Google Scholar PubMed PubMed Central

[6] Ge J, Wang J, Xue D, Zhu Z, Chen Z, Li X, et al. Why does a high-fat diet induce preeclampsia-like symptoms in pregnant rats. Neural Regen Res. 2013 Jul 15;8(20):1872–80. 10.3969/j.issn.1673-5374.2013.20.006. PMID: 25206496. PMCID: PMC4145971.Search in Google Scholar PubMed PubMed Central

[7] Savage AR, Hoho L. Knowledge of pre-eclampsia in women living in Makole Ward, Dodoma, Tanzania. Afr Health Sci. 2016 Jun;16(2):412–9. 10.4314/ahs.v16i2.9. PMID: 27605956. PMCID: PMC4994549.Search in Google Scholar PubMed PubMed Central

[8] Tang Y, Ye W, Liu X, Lv Y, Yao C, Wei J. VEGF and sFLT-1 in serum of PIH patients and effects on the foetus. Exp Ther Med. 2019 Mar;17(3):2123–8. 10.3892/etm.2019.7184. Epub 2019 Jan 18 PMID: 30867699. PMCID: PMC6396009.Search in Google Scholar PubMed PubMed Central

[9] Tarca AL, Romero R, Benshalom-Tirosh N, Than NG, Gudicha DW, Done B, et al. The prediction of early preeclampsia: Results from a longitudinal proteomics study. PLoS One. 2019 Jun 4;14(6):e0217273. 10.1371/journal.pone.0217273. PMID: 31163045. PMCID: PMC6548389.Search in Google Scholar PubMed PubMed Central

[10] Blair JD, Yuen RK, Lim BK, McFadden DE, von Dadelszen P, Robinson WP. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset pre-eclampsia. Mol Hum Reprod. 2013 Oct;19(10):697–708. 10.1093/molehr/gat044. Epub 2013 Jun 13 PMID: 23770704. PMCID: PMC3779005.Search in Google Scholar PubMed PubMed Central

[11] Wen YH, Yang HI, Chou HC, Chen CY, Hsieh WS, Tsou KI, et al. Taiwan Premature Infant Developmental Collaborative Study Group. Association of maternal preeclampsia with neonatal respiratory distress syndrome in very-low-birth-weight infants. Sci Rep. 2019 Sep 13;9(1):13212. 10.1038/s41598-019-49561-8. PMID: 31519996. PMCID: PMC6744454.Search in Google Scholar PubMed PubMed Central

[12] Park HJ, Kim SH, Jung YW, Shim SS, Kim JY, Cho YK, et al. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy. BMC Pregnancy Childbirth. 2014 Jan 20;14:35. 10.1186/1471-2393-14-35. PMID: 24444293. PMCID: PMC3944217.Search in Google Scholar PubMed PubMed Central

[13] Morikawa M, Kato-Hirayama E, Mayama M, Saito Y, Nakagawa K, Umazume T, et al. Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy. PLoS One. 2020 Mar 16;15(3):e0230488. 10.1371/journal.pone.0230488. PMID: 32176740. PMCID: PMC7075561.Search in Google Scholar PubMed PubMed Central

[14] Vizitiu R, Krauss-Grignard M, Garcia V, Valentin L, Samain E, Diemunsch P. Urapidyl for hypertension control in severe pre-eclampsia: a comparative study with nicardipine. Crit Care. 2010;14(Suppl 1):P136. 10.1186/cc8368. Epub 2010 Mar 1 PMCID: PMC2934274.Search in Google Scholar

[15] Mrema D, Lie RT, Østbye T, Mahande MJ, Daltveit AK. The association between pre pregnancy body mass index and risk of preeclampsia: a registry based study from Tanzania. BMC Pregnancy Childbirth. 2018 Feb 21;18(1):56. 10.1186/s12884-018-1687-3. PMID: 29466949. PMCID: PMC5822591.Search in Google Scholar PubMed PubMed Central

[16] Grum T, Seifu A, Abay M, Angesom T, Tsegay L. Determinants of pre-eclampsia/Eclampsia among women attending delivery Services in Selected Public Hospitals of Addis Ababa, Ethiopia: a case control study. BMC Pregnancy Childbirth. 2017 Sep 15;17(1):307. 10.1186/s12884-017-1507-1. PMID: 28915802. PMCID: PMC5603094.Search in Google Scholar PubMed PubMed Central

[17] Roland CS, Hu J, Ren CE, Chen H, Li J, Varvoutis MS, et al. Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia. Cell Mol Life Sci. 2016 Jan;73(2):365–76. 10.1007/s00018-015-2069-x. Epub 2015 Oct 26 PMID: 26496726. PMCID: PMC4846582.Search in Google Scholar PubMed PubMed Central

[18] Wang J, Zhou L, Lei H, Hao F, Liu X, Wang Y, et al. Simultaneous quantification of amino metabolites in multiple metabolic pathways using ultra-high performance liquid chromatography with tandem-mass spectrometry. Sci Rep. 2017 May 3;7(1):1423. 10.1038/s41598-017-01435-7. PMID: 28469184. PMCID: PMC5431165.Search in Google Scholar PubMed PubMed Central

[19] Cruickshank-Quinn C, Zheng LK, Quinn K, Bowler R, Reisdorph R, Reisdorph N. Impact of blood collection tubes and sample handling time on serum and plasma metabolome and lipidome. Metabolites. 2018 Dec 4;8(4):88. 10.3390/metabo8040088. PMID: 30518126. PMCID: PMC6316012.Search in Google Scholar PubMed PubMed Central

[20] Liang Y, Ke X, Xiao Z, Zhang Y, Chen Y, Li Y, et al. Untargeted metabolomic profiling using UHPLC-QTOF/MS reveals metabolic alterations associated with autism. Biomed Res Int. 2020 Sep 11;2020:6105608. 10.1155/2020/6105608. PMID: 32964039. PMCID: PMC7502129.Search in Google Scholar PubMed PubMed Central

[21] Liu M, Tang L, Liu X, Fang J, Zhan H, Wu H, et al. An evidence-based review of related metabolites and metabolic network research on cerebral ischemia. Oxid Med Cell Longev. 2016;2016:9162074. 10.1155/2016/9162074. Epub 2016 May 5 PMID: 27274780. PMCID: PMC4871976.Search in Google Scholar PubMed PubMed Central

[22] Utermann C, Parrot D, Breusing C, Stuckas H, Staufenberger T, Blümel M, et al. Combined genotyping, microbial diversity and metabolite profiling studies on farmed Mytilus spp. from Kiel Fjord. Sci Rep. 2018 May 22;8(1):7983. 10.1038/s41598-018-26177-y. PMID: 29789708. PMCID: PMC5964093.Search in Google Scholar PubMed PubMed Central

[23] Wang D, Shi C, Ge ZH, Wei YX, Liu TT, Wang Y, et al. Study of the mechanism of action of Guanxin Shutong capsules in the treatment of coronary heart disease based on metabolomics. Front Pharmacol. 2021 Mar 25;12:650438. 10.3389/fphar.2021.650438. PMID: 33867992. PMCID: PMC8048374.Search in Google Scholar PubMed PubMed Central

[24] Lin R, Piao M, Song Y, Liu C. Quercetin suppresses AOM/DSS-induced colon carcinogenesis through its anti-inflammation effects in mice. J Immunol Res. 2020 May 21;2020:9242601. 10.1155/2020/9242601. PMID: 32537472. PMCID: PMC7260625.Search in Google Scholar PubMed PubMed Central

[25] Liu Y, Guo JZ, Liu Y, Wang K, Ding W, Wang H, et al. Nuclear lactate dehydrogenase A senses ROS to produce α-hydroxybutyrate for HPV-induced cervical tumor growth. Nat Commun. 2018 Oct 24;9(1):4429. 10.1038/s41467-018-06841-7. PMID: 30356100. PMCID: PMC6200739.Search in Google Scholar PubMed PubMed Central

[26] Kim HK, Son SY, Oh JS, Song YN, Byun JM, Koh Y, et al. Metabolic profiling during acute myeloid leukemia progression using paired clinical bone marrow serum samples. Metabolites. 2021 Aug 31;11(9):586. 10.3390/metabo11090586. PMID: 34564403. PMCID: PMC8471543.Search in Google Scholar PubMed PubMed Central

[27] Bruzzone C, Bizkarguenaga M, Gil-Redondo R, Diercks T, Arana E, García de Vicuña A, et al. SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum. iScience. 2020 Oct 23;23(10):101645. 10.1016/j.isci.2020.101645. Epub 2020 Oct 5. PMID: 33043283. PMCID: PMC7534591.Search in Google Scholar PubMed PubMed Central

[28] Liu Z, Li J, Li M, Chen S, Gao R, Zeng G, et al. Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19. ESC Heart Fail. 2021 Feb;8(1):644–51. 10.1002/ehf2.13151. Epub 2020 Dec 17. PMID: 33336560. PMCID: PMC7835619.Search in Google Scholar PubMed PubMed Central

[29] Zhou B, Lou B, Liu J, She J. Serum metabolite profiles as potential biochemical markers in young adults with community-acquired pneumonia cured by moxifloxacin therapy. Sci Rep. 2020 Mar 10;10(1):4436. 10.1038/s41598-020-61290-x. PMID: 32157124. PMCID: PMC7064523.Search in Google Scholar PubMed PubMed Central

[30] Li X, Xu Z, Lu X, Yang X, Yin P, Kong H, et al. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus. Anal Chim Acta. 2009 Feb 9;633(2):257–62. 10.1016/j.aca.2008.11.058. Epub 2008 Dec 3. PMID: 19166731.Search in Google Scholar PubMed

[31] Sousa AP, Cunha DM, Franco C, Teixeira C, Gojon F, Baylina P, et al. Which role plays 2-hydroxybutyric acid on insulin resistance? Metabolites. 2021 Dec 3;11(12):835. 10.3390/metabo11120835. PMID: 34940595. PMCID: PMC8703345.Search in Google Scholar PubMed PubMed Central

[32] Cobb J, Eckhart A, Motsinger-Reif A, Carr B, Groop L, Ferrannini E. α-Hydroxybutyric acid is a selective metabolite biomarker of impaired glucose tolerance. Diabetes Care. 2016 Jun;39(6):988–95. 10.2337/dc15-2752. Epub 2016 Apr 5. PMID: 27208342.Search in Google Scholar PubMed

[33] Tricò D, Prinsen H, Giannini C, de Graaf R, Juchem C, Li F, et al. Elevated α-hydroxybutyrate and branched-chain amino acid levels predict deterioration of glycemic control in adolescents. J Clin Endocrinol Metab. 2017 Jul 1;102(7):2473–81. 10.1210/jc.2017-00475. PMID: 28482070. PMCID: PMC5505187.Search in Google Scholar PubMed PubMed Central

[34] Chou J, Liu R, Yu J, Liu X, Zhao X, Li Y, et al. Fasting serum α-hydroxybutyrate and pyroglutamic acid as important metabolites for detecting isolated post-challenge diabetes based on organic acid profiles. J Chromatogr B Anal Technol Biomed Life Sci. 2018 Nov 15;1100–1101:6–16. 10.1016/j.jchromb.2018.09.004. Epub 2018 Sep 4. PMID: 30267980.Search in Google Scholar PubMed

[35] Yoshida N, Kitahama S, Yamashita T, Hirono Y, Tabata T, Saito Y, et al. Metabolic alterations in plasma after laparoscopic sleeve gastrectomy. J Diabetes Investig. 2021 Jan;12(1):123–9. 10.1111/jdi.13328. Epub 2020 Jul 26. PMID: 32563200. PMCID: PMC7779268.Search in Google Scholar PubMed PubMed Central

[36] Nemutlu E, Orgul G, Recber T, Aydin E, Ozkan E, Turgal M, et al. Metabolic infrastructure of pregnant women with trisomy 21 fetuses; Metabolomic analysis. Z Geburtshilfe Neonatol. 2019 Oct;223(5):297–303. 10.1055/a-0877-7869. Epub 2019 May 27 PMID: 31132797.Search in Google Scholar PubMed

[37] Martin-Lorenzo M, Ramos-Barron A, Gutierrez-Garcia P, Martin-Blazquez A, Santiago-Hernandez A, Rodrigo Calabia E, et al. Urinary spermidine predicts and associates with in-hospital acute kidney injury after cardiac surgery. Antioxid (Basel). 2021 Jun 2;10(6):896. 10.3390/antiox10060896. PMID: 34199603. PMCID: PMC8229689.Search in Google Scholar PubMed PubMed Central

[38] Pu J, Liu Y, Zhang H, Tian L, Gui S, Yu Y, et al. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry. 2021 Aug;26(8):4265–76. 10.1038/s41380-020-0645-4. Epub 2020 Jan 20. PMID: 31959849. PMCID: PMC8550972.Search in Google Scholar PubMed PubMed Central

[39] Boulesteix AL, Strimmer K. Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Brief Bioinforma. 2007;8:32–44.10.1093/bib/bbl016Search in Google Scholar PubMed

[40] Thevenot EA, Roux A, Xu Y, Ezan E, Junot C. Analysis of the human adult urinary metabolome variations with age, body mass index and gender by implementing a comprehensive workflow for univariate and OPLS statistical analyses. J Proteome Res. 2015;14:3322–35.10.1021/acs.jproteome.5b00354Search in Google Scholar PubMed

[41] Karnovsky A, Weymouth T, Hull T, Tarcea VG, Scardoni G, Laudanna C, et al. Metscape 2 bioinformatics tool for the analysis and visualization of metabolomics and gene expression data. Bioinformatics. 2012 Feb 1;28(3):373–80. 10.1093/bioinformatics/btr661. Epub 2011 Nov 30 PMID: 22135418. PMCID: PMC3268237.Search in Google Scholar PubMed PubMed Central

[42] Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003 Nov;13(11):2498–504. 10.1101/gr.1239303. PMID: 14597658. PMCID: PMC403769.Search in Google Scholar PubMed PubMed Central

[43] Shi D, Yan R, Lv L, Jiang H, Lu Y, Sheng J, et al. The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism. 2021 May;118:154739. 10.1016/j.metabol.2021.154739. Epub 2021 Mar 2. PMID: 33662365. PMCID: PMC7920809.Search in Google Scholar PubMed PubMed Central

[44] Bahado-Singh RO, Syngelaki A, Akolekar R, Mandal R, Bjondahl TC, Han B, et al. Validation of metabolomic models for prediction of early-onset preeclampsia. Am J Obstet Gynecol. 2015 Oct;213(4):530.e1–530.e10. 10.1016/j.ajog.2015.06.044. Epub 2015 Jun 23 PMID: 26116099.Search in Google Scholar PubMed

[45] He J, Liu K, Hou X, Lu J. Identification and validation of key non-coding RNAs and mRNAs using co-expression network analysis in pre-eclampsia. Med (Baltim). 2021 Apr 9;100(14):e25294. 10.1097/MD.0000000000025294. PMID: 33832098. PMCID: PMC8036074.Search in Google Scholar PubMed PubMed Central

[46] Wu G, Meininger CJ, McNeal CJ, Bazer FW, Rhoads JM. Role of L-arginine in nitric oxide synthesis and health in humans. Adv Exp Med Biol. 2021;1332:167–87. 10.1007/978-3-030-74180-8_10. PMID: 34251644.Search in Google Scholar PubMed

[47] Harville EW, Li YY, Pan K, McRitchie S, Pathmasiri W, Sumner S. Untargeted analysis of first trimester serum to reveal biomarkers of pregnancy complications: a case-control discovery phase study. Sci Rep. 2021;11(1):3468. Published 2021 Feb 10. 10.1038/s41598-021-82804-1.Search in Google Scholar PubMed PubMed Central

[48] Ghaemi SZ, Forouhari S, Dabbaghmanesh MH, Sayadi M, Bakhshayeshkaram M, Vaziri F, et al. A prospective study of selenium concentration and risk of preeclampsia in pregnant Iranian women: a nested case-control study. Biol Trace Elem Res. 2013 May;152(2):174–9. 10.1007/s12011-013-9614-y. Epub 2013 Jan 26 PMID: 23354545.Search in Google Scholar PubMed

[49] Haque MM, Moghal MM, Sarwar MS, Anonna SN, Akter M, Karmakar P, et al. Low serum selenium concentration is associated with preeclampsia in pregnant women from Bangladesh. J Trace Elem Med Biol. 2016 Jan;33:21–5. 10.1016/j.jtemb.2015.08.002. Epub 2015 Aug 20 PMID: 26653739.Search in Google Scholar PubMed

[50] Maleki A, Fard MK, Zadeh DH, Mamegani MA, Abasaizadeh S, Mazloomzadeh S. The relationship between plasma level of Se and preeclampsia. Hypertens Pregnancy. 2011;30(2):180–7. 10.3109/10641950903322931. Epub 2010 Sep 6 PMID: 20818958.Search in Google Scholar PubMed

[51] Eze SC, Ododo NA, Ugwu EO, Enebe JT, Onyegbule OA, Eze IO, et al. Serum selenium levels of pre-eclamptic and normal pregnant women in Nigeria: A comparative study. PLoS One. 2020 Aug 27;15(8):e0238263. 10.1371/journal.pone.0238263. PMID: 32853288. PMCID: PMC7451566.Search in Google Scholar PubMed PubMed Central

[52] Roy AC, Ratnam SS, Karunanithy R. Amniotic fluid selenium status in pre-eclampsia. Gynecol Obstet Invest. 1989;28(3):161–2. 10.1159/000293557. PMID: 2807037.Search in Google Scholar PubMed

[53] Ogrizek Pelkič K, Sobočan M, Takač I. Low selenium levels in amniotic fluid correlate with small-for-gestational age newborns. Nutrients. 2020 Oct 5;12(10):3046. 10.3390/nu12103046. PMID: 33027985. PMCID: PMC7600462.Search in Google Scholar PubMed PubMed Central

[54] Enebe JT, Dim CC, Ugwu EO, Enebe NO, Meka IA, Obioha KC, et al. Serum antioxidant micronutrient levels in pre-eclamptic pregnant women in Enugu, south-East Nigeria: a comparative cross-sectional analytical study. BMC Pregnancy Childbirth. 2020 Jul 6;20(1):392. 10.1186/s12884-020-03081-w. PMID: 32631273. PMCID: PMC7339396.Search in Google Scholar PubMed PubMed Central

[55] Hovdenak N, Haram K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2012 Oct;164(2):127–32. 10.1016/j.ejogrb.2012.06.020. Epub 2012 Jul 6 PMID: 22771225.Search in Google Scholar PubMed

[56] Omotayo MO, Dickin KL, O’Brien KO, Neufeld LM, De Regil LM, Stoltzfus RJ. Calcium supplementation to prevent preeclampsia: Translating guidelines into practice in low-income countries. Adv Nutr. 2016 Mar 15;7(2):275–8. 10.3945/an.115.010736. PMID: 26980810. PMCID: PMC4785477.Search in Google Scholar PubMed PubMed Central

Received: 2022-09-23
Revised: 2022-12-16
Accepted: 2023-01-14
Published Online: 2023-02-28

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 6.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0572/html?lang=en
Scroll to top button